Keck Medicine of USC Koreatown is a clinical research site located in Los Angeles, California, United States 90020.
Crixeo Clinical Trials Trust Score: 26/100 (FAILING). This profile has not yet been claimed by the site owner.
Keck Medicine of USC Koreatown has participated in 40 clinical trials with 39 currently active.
Therapeutic areas: Pathologic Stage I Cutaneous Merkel Cell Carcinoma AJCC v8, Pathologic Stage II Cutaneous Merkel Cell Carcinoma AJCC v8, Pathologic Stage III Cutaneous Merkel Cell Carcinoma AJCC v8.
Sponsors: National Cancer Institute (NCI), University of Southern California, NRG Oncology.
Is this your site? Claim your profile and control the information sponsors and patients see.
Browse all research sites in California · View every site in Los Angeles
Trust Score: 26/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Keck Medicine of USC Koreatown has a Crixeo Trust Score of 26/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Keck Medicine of USC Koreatown has 40 clinical trials on record, with 39 currently active. Their work covers Pathologic Stage I Cutaneous Merkel Cell Carcinoma AJCC v8, Pathologic Stage II Cutaneous Merkel Cell Carcinoma AJCC v8, Pathologic Stage III Cutaneous Merkel Cell Carcinoma AJCC v8.
Keck Medicine of USC Koreatown has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.